![Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/cf7c63e7-298c-40aa-ace2-39bf59630ff1/gr1.gif)
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
![Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12325-021-01646-5/MediaObjects/12325_2021_1646_Fig2_HTML.png)
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy
![Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-023-02545-9/MediaObjects/12931_2023_2545_Fig1_HTML.png)
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text
![Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369219300145-gr1.jpg)
Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect
![Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/410388bf4ca6316b0fbca72a61ab191f5ae501af/7-Figure2-1.png)
Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
![BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone](https://hardoctor.files.wordpress.com/2023/04/bpco-rischio-di-eventi-cardiovascolari-e-terapia-combinata.png)
BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
![JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations](https://www.mdpi.com/jcm/jcm-11-06623/article_deploy/html/images/jcm-11-06623-g001.png)
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig1_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.2147%2FCOPD.S350167&id=dcop_a_12164092_uf0001_c.jpg)